期刊文献+

紫云英苷通过抑制HIF-1α诱导的糖酵解途径发挥抗卵巢肿细胞作用的研究 被引量:13

Study of the effect of astragalin on proliferation of ovarian cancer cells by inhibiting the glycolytic pathway induced Via HIF-1α
下载PDF
导出
摘要 目的探讨紫云英苷在2 D及3 D细胞培养条件下对人卵巢癌OVCAR-8细胞的增殖作用及其可能机制。方法采用CCK-8试剂盒检测紫云英苷在2 D培养水平对OVCAR-8细胞增殖活力的作用;采用3 D细胞增殖活性检测试剂盒检测紫云英苷在3 D培养水平对OVCAR-8细胞增殖活力的作用;采用划痕实验检测紫云英苷对OVCAR-8细胞迁移能力的作用;采用凋亡试剂盒检测细胞凋亡水平;采用Western blot法在2 D及3 D培养条件下检测紫云英苷对OVCAR-8细胞细胞凋亡相关蛋白Bcl2(B-cell lymphoma 2)、Bax(Bcl-2-associated X protein)和cleaved-caspase-3以及糖酵解相关蛋白Glut(Glucose transporter) 1、Glut3、HK2(Hexokinase 2)、PDK(Pyruvate dehydrogenase lipoamide kinase) 1、PDK3以及HIF(Hypoxia-inducible factor)-1α的蛋白表达水平的影响;采用ELISA试剂盒检测HK2活性。结果 4~100μmol/L紫云英苷在2 D培养条件下对OVCAR-8细胞增殖均有抑制作用,且呈剂量-时间依赖效应关系(P <0. 05);紫云英苷可在3 D培养条件下明显抑制OVCAR-8细胞增殖(P <0. 05);同时,紫云英苷可明显抑制OVCAR-8细胞迁移能力。此外,紫云英苷处理后细胞凋亡水平明显增高,且紫云英苷处理在2 D及3 D培养条件下均可抑制Bcl2、Glut1、Glut3、HK2、PDK1和PDK3蛋白的表达,增加Bax及cleaved-caspase-3蛋白水平并抑制3 D培养诱导的HIF-1α的蛋白表达,此外,紫云英苷在2 D培养条件下可抑制HK2活性,均呈一定的剂量依赖效应关系(P <0. 05)。结论紫云英苷在2 D及3 D培养条件下对卵巢癌OVCAR-8细胞增殖均具有抑制作用。且可能通过抑制HIF-1α诱导的糖酵解通路以及激活线粒体凋亡通路。 Objective The objective of this study was to explore the effect of astragalin on human ovarian cancer OVCAR-8 cells in 2 D and 3 D culture conditions and its possible mechanism.Methods CCK-8 assay was use to detect the effect of astragalin on the proliferation of OVCAR-8 cells in 2 D culture conditions.The 3 D cell proliferation activity assay kit was used to detect the effect of astragalin on OVCAR-8 cells in 3 D culture conditions.Cell apoptosis kit was used to detect the cell apoptosis rate after astragaline treatment.In addition,Western blot was used to detect the levels of apoptosis related proteins such as Bcl2(B-cell lymphoma 2),Bax(Bcl-2-associated X protein),cleaved-caspase-3 and glycolysis related proteins such as Glut-1(Glucose transporter-1),Glut3,HK2(Hexokinase 2),PDK-1(Pyruvate dehydrogenase lipoamide kinase-1),PDK3 and HIF-1α(hypoxia-inducible factor-1α)in OVCAR-8 cells after astragaline treatments in 2 D and 3 D culture conditions.HK2 activity was detected in OVCAR-8 cells by Elisa.Results Astragaline at doses of 4~100μmol/L significantly inhibited the proliferation of OVCAR-8 cells in 2 D culture conditions,and showed a dose-and time-dependent manner(P<0.05).Astragalin significantly inhibited the proliferation of OVCAR-8 cells in 3 D culture conditions(P<0.05).Astragalin also significantly inhibited the migration ability of OVCAR-8 cells(P<0.05).In addition,astragaline significantly increased apoptosis rate,decreased the levels of Bcl2,Glut1,Glut3,HK2,PDK1 and PDK3 proteins and increased the levels of Bax and cleaved-caspase-3 proteins in OVCAR-8 cells both in 2 D and 3 D culture conditions(P<0.05).Astragaline significantly decreased the expression of HIF-1αin OVCAR-8 cells in 3 D culture conditions(P<0.05).In addition,astragalin decreased HK2 activity in OVCAR-8 cells under 2 D culture conditions in a dose-dependent manner(P<0.05).Conclusion Astragalin has an inhibitory effect on the proliferation of OVCAR-8 cells both in 2 D and 3 D culture conditions.Its mechanism may be related to inhibiting glycolytic and the mitochondrial apoptotic pathways induced by HIF-1α.
作者 宋玲 付琼 SONG Ling;FU Qiong(Department of Gynecology and Obstetrics,Chengdu Second People's Hospital,Chengdu 610017,China)
出处 《实用肿瘤学杂志》 CAS 2018年第6期503-509,共7页 Practical Oncology Journal
关键词 紫云英苷 卵巢癌 糖酵解 凋亡 3 D 缺氧诱导因子 Astragaline Ovarian cancer Glycolysis Apoptosis 3 D HIF-1α
  • 相关文献

参考文献1

二级参考文献60

  • 1Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12: 5447-5454.
  • 2Wang GL, Jiang BH, Rue EA and Semenza GL. Hypoxia-inducible factor-I is a basic-helix-Ioop-helix-Pas heterodimer regulated by cellular 0-2 tension. Proc Natl Acad Sci USA 1995,92: 5510-5514.
  • 3Keith B, Johnson RS and Simon Me. HIFlalpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012, 12: 9-22.
  • 4Kaelin WG, Jr and Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008, 30: 393-402.
  • 5Semenza GL. Targeting HIF-I for cancer therapy. Nat Rev Cancer 2003, 3: 721-732.
  • 6Warburg O. On the origin of cancer cells. Science 1956, 123: 309-314.
  • 7Dang CV and Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999,24: 68-72.
  • 8Semenza GL. Defining the role of hypoxia-inducible factor I in cancer biology and therapeutics. Oncogene 2010, 29: 625-634.
  • 9Gordan JD, Thompson CB and Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12: 108-113.
  • 10Gleadle JM and Ratcliffe PJ. Induction of hypoxia-inducible factor-I, erythropoietin, vascular endothelial growth factor, and glucose transporter-I by hypoxia: evidence against a regulatory role for Src kinase. Blood 1997, 89: 503-509.

共引文献19

同被引文献166

引证文献13

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部